Upjohn, SmithKline End Pact
Neither company would comment further on their decision.
Analysts have previously said that Upjohn is developing its
own heart drug. Upjohn is based in Kalamazoo, Mich.
SmithKline has its headquarters in London and its U.S.
operations are based in Philadlephia.